InvestorsHub Logo
Followers 151
Posts 18284
Boards Moderated 1
Alias Born 04/05/2019

Re: Threeflight post# 26578

Monday, 08/17/2020 9:07:23 AM

Monday, August 17, 2020 9:07:23 AM

Post# of 44323
New investors

CTYX FAST TRACK DD

April
8 filings
Including Attorney's letter
Went pink current
2 PR
Updated Webpage

MAY
3 board members from multi million dollar companies
2 PR

June
1 new Director of Communication coming from multi Billion Dollar company to OTC.
UPDATED WEBPAGE AGAIN

JULY NEWSSS WEEEE Just getting started.

"07/06/2020
Boca Raton, FL, July 06, 2020 (GLOBE NEWSWIRE) -- Connectyx Technologies Holdings Group, Inc. (OTC: CTYX) (“Connectyx” or the “Company”), a development-stage biomedical company focusing on novel treatments for rare diseases today announced it is in licensing discussions for a novel monoclonal antibody (mAB) to treat brain cancer. The Company plans to grows.."

"Connectyx is currently involved in licensing discussions with the owner of the intellectual property for an exclusive worldwide license. This product leverages the Company’s Scientific Advisory Board, that has deep experience in clinical development and manufacturing in this field.

“Our potential first target indication addresses an area of urgent underserved medical need,"